Skip to content

Real-World Study on the Impact of Preoperative Carbohydrate Beverage Intake on the Recovery of Elective Surgery Patients under the Enhanced Recovery After Surgery (ERAS)

Real-World Study on the Impact of Preoperative Carbohydrate Beverage Intake on the Recovery of Elective Surgery Patients under the Enhanced Recovery After Surgery (ERAS)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500097820
Enrollment
Unknown
Registered
2025-02-26
Start date
2025-02-28
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing elective surgery requiring at least 6 hours of fasting

Interventions

Fasting:None
Preoperative Oral Carbohydrate:None

Sponsors

Shandong Institute of Pharmaceutical Research Ethics Committee
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age requirement: The subjects were 18 to 70 years old; 2. Disease status: Elective patients were instructed to maintain a fasting state for a minimum of 6 hours prior to the surgical procedure; 3. Voluntary Participation: Patients were invited to participate in the study on a voluntary basis. After being thoroughly informed about the study objectives, procedures, and potential risks, they were required to sign an informed consent form. Participants must also be willing to adhere to all study requirements, including regular follow-up visits and data collection, which can be completed during the inpatient phase; 4. Nutritional Status: There is no evidence of any impairment in nutrient absorption or metabolism; 5. (ASA) classification: ASA ?-?;

Exclusion criteria

Exclusion criteria: 1. Gastrointestinal Function: Patients with compromised gastrointestinal function, including conditions such as gastroparesis, gastric obstruction, gastroesophageal reflux disease (GERD), peptic ulcer disease, gastric carcinoma, pyloric stenosis, functional dyspepsia, intestinal obstruction, and intestinal ischemia, etc; 2. In conjunction with other comorbidities: individuals diagnosed with diabetes mellitus, as well as those suffering from severe cardiac, pulmonary, hepatic, or renal dysfunction, hypertension, or cerebrovascular accidents; 3. History of allergy: Patients with a documented history of severe allergic reactions to any components of the study interventions, as well as those with a previous history of allergic reactions to narcotic medications. 4. Patients presenting with a mental illness or serious psychological problem (as confirmed by medical history); 5. Investigator judgment: Other factors that the investigator believes may affect the study results or the safety of the participants;

Design outcomes

Primary

MeasureTime frame
Postoperative recovery: fasting blood glucose, fasting triglyceride and TyG;Postoperative recovery: Adverse reactions occurred within 12 hours after surgery;Subjective comfort:Hunger, Thirst, Anxiety;

Secondary

MeasureTime frame
Actual preoperative fasting management;Hospital stay and cost;

Countries

China

Contacts

Public ContactBing Wang

Shandong Institute of Pharmaceutical Research Ethics Committee

2301532477@qq.com+86 20 38019026

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026